S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

UNCY Unicycive Therapeutics Inc

0.35

-0.0033 (-0.93%)

07 Sep 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Unicycive Therapeutics Charts.

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Unicycive Therapeutics Charts.

Unicycive Therapeutics Inc News

Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Thursday 5 September 2024 (3 days ago) • GlobeNewswire Inc.

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Tuesday 3 September 2024 (5 days ago) • GlobeNewswire Inc.

Unicycive Therapeutics to Present Three Posters at the American Society of Nephrology (ASN) Kidney Week 2024
Monday 26 August 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 August 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 August 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 14 August 2024 (4 weeks ago) • Edgar (US Regulatory)

Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
Wednesday 14 August 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (4 weeks ago) • Edgar (US Regulatory)

Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)
Wednesday 17 July 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Wednesday 17 July 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 17 July 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 16 July 2024 (2 months ago) • Edgar (US Regulatory)

More Unicycive Therapeutics Inc News Articles

AUD vs US Dollar

Verizon Communications

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions